Inhibition of tumor metastasis by adoptive transfer of IL-12-activated V?14 NKT cells
Open Access
- 15 February 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 91 (4) , 523-528
Abstract
A unique lymphocyte lineage, the Vα14 NKT cells, expresses both NK1.1 and an invariant antigen receptor encoded by Vα14 and Jα281 gene segments. Vα14 NKT cells play crucial roles in various immune responses, including autoimmune diseases, allergic reactions and anti‐tumor immunity. Vα14 NKT cells were demonstrated to be essential for anti‐tumor effect of IL‐12 in vivo. Here, we report that adoptive transfer of IL‐12‐activated Vα14 NKT cells prevents hepatic metastasis of B16 melanoma. The injection of large amounts of IL‐2, IL‐4, and IFN‐γ, which are cytokines produced by activated Vα14 NKT cells, exhibited no significant inhibition of the metastasis of this melanoma. The cells prepared from the liver of IL‐12‐injected mice expressed a potent cytotoxic activity on B16 melanoma cells in vitro. Although the adoptive transfer of IL‐12‐activated Vα14 NKT cells prevents hepatic metastasis of B16 melanoma, activated NK cells from IL‐12‐injected RAG‐1−/− mice failed to inhibit the metastasis of this melanoma. Thus, the anti‐tumor effect of IL‐12 can be replaced by adoptive transfer of IL‐12‐activated Vα14 NKT cells but not by IL‐12‐activated NK cells, suggesting a minor role of NK cells for the IL‐12‐mediated anti‐tumor effect in this experimental system. Moreover, our studies have suggested the involvement of direct cytotoxic mechanisms rather than cytokine‐mediated immune responses at the effector phase of the Vα14 NKT cell‐mediated anti‐tumor activity.Keywords
This publication has 40 references indexed in Scilit:
- Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of TumorsScience, 1997
- CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by GlycosylceramidesScience, 1997
- Vα14+ NK T cells: A novel lymphoid cell lineage with regulatory functionJournal of Allergy and Clinical Immunology, 1996
- Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells.Proceedings of the National Academy of Sciences, 1996
- Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis.Journal of Experimental Medicine, 1995
- Predominant expression of invariant Vα14+ TCR α chain in NK1.1+ T cell populationsInternational Immunology, 1995
- An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.Journal of Experimental Medicine, 1994
- The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.Journal of Experimental Medicine, 1993
- A novel population of T-cell receptor αβ-bearing thymocytes which predominantly expresses a single Vβ gene familyNature, 1987
- Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes.Journal of Experimental Medicine, 1987